← Back to Clinical Trials
Recruiting NCT05545176

NCT05545176 The Validation and Development of Termination-of-Resuscitation (TOR) Rules in OHCA Patients in Asia Countries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05545176
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Out-Of-Hospital Cardiac Arrest
Study Type OBSERVATIONAL
Enrollment 140,000 participants
Start Date 2007-01-01
Primary Completion 2032-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
termination of resuscitation rules

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 140,000 participants in total. It began in 2007-01-01 with a primary completion date of 2032-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Objectives/Hypotheses 1. Prehospital termination-of-resuscitation (TOR) rules were developed in North American and European sites. Whether they remained valid in different geographic, ethnic, and cultural background areas is still under debate. 2. Differences in characteristics of out-of-hospital cardiac arrests (OHCAs) and configurations of emergency medical service (EMS) between the Western and Asian countries, including relatively lower rate of presenting shockable rhythm (i.e. ventricular fibrillation / ventricular tachycardia; VF/VT), lower rates of bystander CPR, less advanced life support (ALS) implementation, and less public access defibrillators, might create potential threats to the prediction accuracy of TOR rules. 3. We aim to conduct a study to validate the performance of ever published TOR rules in Asian OHCA population, including non-traumatic, traumatic, and pediatric OHCA patients. Furthermore, assess the possible variables that may impact the performance of TOR rules. 4. We also aim to develop new TOR rules based on PAROS registry for Asia population, focusing on non-traumatic, traumatic, and pediatric OHCA patients, respectively.

Eligibility Criteria

Inclusion Criteria: * out of hospital cardiac arrest (OHCA) patients Exclusion Criteria: * age \<18 years * non-EMS transport to the emergency department * obvious signs of death (e.g. decapitation, rigor mortis, lividity, and decapitation) or having do-not-resuscitate (DNR) orders * missing data despite meeting the inclusion criteria.

Contact & Investigator

Central Contact

Shu-Hsien Hsu, MPH

✉ pedroe929@gmail.com
Principal Investigator

Shu-Hsien Hsu, MPH

PRINCIPAL INVESTIGATOR

National Taiwan University

Frequently Asked Questions

Who can join the NCT05545176 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Out-Of-Hospital Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05545176 currently recruiting?

Yes, NCT05545176 is actively recruiting participants. Contact the research team at pedroe929@gmail.com for enrollment information.

Where is the NCT05545176 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT05545176 clinical trial?

NCT05545176 is sponsored by National Taiwan University Hospital. The principal investigator is Shu-Hsien Hsu, MPH at National Taiwan University. The trial plans to enroll 140,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology